United Therapeutics: The Market Sees The Erosion, Not The Refill - Buy (NASDAQ:UTHR)
· seekingalpha.com
United Therapeutics' declines are real but they sit in ~32% of the business, tax-normalized earnings power is $1.05 billion. See why UTHR stock is a Buy now.
United Therapeutics Corporation ( UTHR ) is down ~19% from its 52-week high of $609.35 because revenue declined for two consecutive quarters. Investors seem to ...